sulpiride has been researched along with Catatonia in 4 studies
Sulpiride: A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. (From Merck Index, 11th ed)
sulpiride : A member of the class of benzamides obtained from formal condensation between the carboxy group of 2-methoxy-5-sulfamoylbenzoic acid and the primary amino group of (1-ethylpyrrolidin-2-yl)methylamine.
Catatonia: A neuropsychiatric disorder characterized by one or more of the following essential features: immobility, mutism, negativism (active or passive refusal to follow commands), mannerisms, stereotypies, posturing, grimacing, excitement, echolalia, echopraxia, muscular rigidity, and stupor; sometimes punctuated by sudden violent outbursts, panic, or hallucinations. This condition may be associated with psychiatric illnesses (e.g., SCHIZOPHRENIA; MOOD DISORDERS) or organic disorders (NEUROLEPTIC MALIGNANT SYNDROME; ENCEPHALITIS, etc.). (From DSM-IV, 4th ed, 1994; APA, Thesaurus of Psychological Index Terms, 1994)
| Excerpt | Relevance | Reference |
|---|---|---|
| " The authors present a case of amisulpiride-induced catatonia, further evaluation suggested neuroleptic malignant syndrome (NMS) and showed the occurrence of temporal lobe epilepsy (TLE) and underlying brain pathology with marked frontoparietal atrophy and periventricular white matter hyperintensities." | 3.75 | Catatonia, neuroleptics and brain damage--a case report. ( Chandran, M; El-Shazly, M, 2009) |
| "Toxic epidermal necrolysis (Lyell syndrome) developed in a 43-year woman treated with carbamazepine, perazine, and sulpiride for recurrent manic bipolar disorder." | 3.68 | [Electroconvulsive therapy in treatment of acute life threatening catatonia in toxic epidermal necrolysis (Lyell syndrome)]. ( Beckmann, H; Kornhuber, J; Weller, M, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chandran, M | 1 |
| El-Shazly, M | 1 |
| Saba, G | 1 |
| Rocamora, JF | 1 |
| Kalalou, K | 1 |
| Benadhira, R | 1 |
| Plaze, M | 1 |
| Aubriot-Delmas, B | 1 |
| Januel, D | 1 |
| Weller, M | 1 |
| Kornhuber, J | 1 |
| Beckmann, H | 1 |
| Eckmann, F | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| "Interventional Triple-negative Placebo-controlled Personalized Prospective Study Evaluation of the Efficacy and Safety of Noninvasive Neuromodulation of TMS in Subjects With Catatonia"[NCT06176456] | 60 participants (Anticipated) | Interventional | 2023-11-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for sulpiride and Catatonia
| Article | Year |
|---|---|
[Clinical studies of sulpride on long standing hospitalized schizophrenic patients].
Topics: Adult; Autistic Disorder; Catatonia; Clinical Trials as Topic; Depressive Disorder, Major; Drug Eval | 1974 |
3 other studies available for sulpiride and Catatonia
| Article | Year |
|---|---|
Catatonia, neuroleptics and brain damage--a case report.
Topics: Amisulpride; Antipsychotic Agents; Atrophy; Catatonia; Epilepsy, Temporal Lobe; Female; Frontal Lobe | 2009 |
Catatonia and transcranial magnetic stimulation.
Topics: Adolescent; Amisulpride; Antipsychotic Agents; Catatonia; Female; Humans; Prefrontal Cortex; Schizop | 2002 |
[Electroconvulsive therapy in treatment of acute life threatening catatonia in toxic epidermal necrolysis (Lyell syndrome)].
Topics: Adult; Bipolar Disorder; Carbamazepine; Catatonia; Drug Therapy, Combination; Electroconvulsive Ther | 1992 |